Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression

HER2 is a promising target for immunotherapeutic interventions with T cell-based approaches since it is amplified and overexpressed in 20–30% of breast cancers. However, several previous studies including ours showed that HER2-overexpressing tumors may escape cytotoxic T lymphocyte-mediated lysis by...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Inoue, Masayuki, Mimura, Kousaku, Izawa, Shinichiro, Shiraishi, Kensuke, Inoue, Ayako, Shiba, Shugo, Watanabe, Mitsuaki, Maruyama, Takanori, Kawaguchi, Yoshihiko, Inoue, Shingo, Kawasaki, Tomonori, Choudhury, Aniruddha, Katoh, Ryohei, Fujii, Hideki, Kiessling, Rolf, Kono, Koji
פורמט: Artigo
שפה:Inglês
יצא לאור: Landes Bioscience 2012
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494624/
https://ncbi.nlm.nih.gov/pubmed/23170258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21056
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים